Join Growin Stock Community!

亞諾法4133.TW Overview

TW StockBiotech. & Medical
(No presentation for 4133)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

亞諾法（4133）Overall Performance

亞諾法（4133）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

亞諾法（4133） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

亞諾法（4133）Key Information

亞諾法（4133）Profile

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.

亞諾法（4133）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.02
PE Ratio (TTM)
-
Forward PE
21.83
PS Ratio (TTM)
4.21
PB Ratio
1.18
Price-to-FCF
22.85
METRIC
VALUE
vs. INDUSTRY
Gross Margin
44.35%
Net Margin
-0.32%
Revenue Growth (YoY)
-1.11%
Profit Growth (YoY)
-4.56%
3-Year Revenue Growth
-8.05%
3-Year Profit Growth
-10.33%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.02
PE Ratio (TTM)
-
Forward PE
21.83
PS Ratio (TTM)
4.21
PB Ratio
1.18
Price-to-FCF
22.85
Gross Margin
44.35%
Net Margin
-0.32%
Revenue Growth (YoY)
-1.11%
Profit Growth (YoY)
-4.56%
3-Year Revenue Growth
-8.05%
3-Year Profit Growth
-10.33%
4133.TW logo

4133

亞諾法

24.45D

-2.86%

(-0.03)

  • When is 4133's latest earnings report released?

    The most recent financial report for 亞諾法 (4133) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4133's short-term business performance and financial health. For the latest updates on 4133's earnings releases, visit this page regularly.

  • What is the operating profit of 4133?

    According to the latest financial report, 亞諾法 (4133) reported an Operating Profit of 5.11M with an Operating Margin of 6.09% this period, representing a growth of 47.14% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4133's revenue growth?

    In the latest financial report, 亞諾法 (4133) announced revenue of 83.94M, with a Year-Over-Year growth rate of -4.66%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4133 have?

    At the end of the period, 亞諾法 (4133) held Total Cash and Cash Equivalents of 377.83M, accounting for 0.28 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4133 go with three margins increasing?

    In the latest report, 亞諾法 (4133) achieved the “three margins increasing” benchmark, with a gross margin of 46.7%%, operating margin of 6.09%%, and net margin of 12.57%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4133's profit trajectory and future growth potential.

  • Is 4133's EPS continuing to grow?

    According to the past four quarterly reports, 亞諾法 (4133)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.17. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4133?

    亞諾法 (4133)'s Free Cash Flow (FCF) for the period is -5.35M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 156.01% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.